Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Summa Equity Acquires Finnish Antibody Manufacturer HyTest
September 7, 2018

Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry. The company operates in a global market where growth is driven by an aging population, innovation and increasing investments in medical care. The investment is Summa Equity’s first in the Finnish market. The acquired company, based in Turku, Finland has around 100 employees.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: